Skip to main content

Starling Oncology, Inc 10-Q for FY2025 Q2

Starling Oncology, Inc. (STLN)

10-Q 2025-08-13 For: 2025-06-30
View Original
Added on April 06, 2026

About this 10-Q

Starling Oncology, Inc filed this 10-Q on August 13, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$119.8M
up 21.5% from $98.58M a year earlier
Net loss
$17.01M
compared with a net loss of $15.48M a year earlier
Diluted EPS
-$0.15
compared with -$0.17 a year earlier